Sulfoximines Reactions
FULL PAPER
5.75 (d, J = 10.7 Hz, 1H), 6.46 (d, J = 11.8 Hz, 1H), 7.18 (m, 2H), 7.27–
7.35 ppm (m, 3H); 13C NMR (75 MHz, CDCl3): d = 18.5 (d), 19.3 (d),
21.4 (d), 21.6 (d), 21.7 (d), 21.7 (d), 28.8 (d), 29.2 (d), 50.0 (d), 51.5 (d),
68.4 (d), 68.5 (d), 128.1 (d), 129.8 (d), 126.8 (d), 128.8 (d), 131.4 (d), 136.5
(d), 140.4 (u), 142.7 ppm (u).
b) A suspension of CuI (140 mg, 0.73 mmol) in Et2O (5 mL) at ꢁ408C
was treated with MeLi (0.6 mL of 5% solution in Et2O, 1.34 mmol).
After the yellow mixture was stirred for 1 h, a solution of the alkenyl sul-
foximine (Z)-1b (100 mg, 0.24 mmol) in Et2O (2 mL) was added. The
mixture was stirred for 1 h at ꢁ408Cand then allowed to warm room
temperature and stirred for 10 h. The mixture was quenched with aque-
ous NH4Cl and extracted with Et2O. The combined organic phases were
dried (MgSO4) and concentrated in vacuo. GC-MS analysis showed the
formation of (E)-9b, 16b and 5% of (Z,E)-17b. Purification by chroma-
tography (hexane) yielded alkene (E)-9b along with the dimethyl alkene
16b (49 mg) in a ratio of 9:1 as a colorless liquid. Separation by HPLC
(pentane) gave (E)-9b (42 mg, 64%) and 16b (5 mg, 8%) as colorless
liquids.
Reaction of( Z)-1a and (E)-1a with LiCu(CH=CH2)2: A suspension of
A
CuI (282 mg, 1.48 mmol) in Et2O (80 mL) at ꢁ408Cwas treated with vi-
nyllithium (approximately 70 mg, 2 mmol) in Et2O (10 mL). After the
mixture was stirred for 1 h, it was warmed to ꢁ158Cand a solution of
(Z)-1a (156 mg, 0.39 mmol) in Et2O (2 mL) was added. The mixture was
warmed within 1.5 h to 08Cand stirring was continued at this tempera-
ture for 2.5 h. Then saturated aqueous NH4Cl/NH3 was added. Purifica-
tion by chromatography (hexane/EtOAc 80:20) (Rf = 0.69) gave a mix-
ture (75 mg) of (E)-9ad (66% chemical yield), (Z)-9ad (3% chemical
yield) and (Z,E)-17ab (1% chemical yield) in a ratio of 94:4:2 as a color-
less oil.
Triethyl [(5S,6R,E)-6-methylnona-1,7-dien-5-yloxy]silane [(E)-9b]: [a]D
= +15.0 (c= 0.7 in CH2Cl2); 1H NMR (300 MHz, CDCl3): d = 0.50–
0.57 (m, 6H), 0.87 (d, J = 6.9 Hz, 3H), 0.89 (t, J = 7.7 Hz, 9H), 1.35–
1.32 (m, 2H), 1.59 (d, J = 5.8 Hz, 3H), 1.88–1.98 (m, 1H), 2.01–2.11 (m,
1H), 2.13–2.22 (m, 1H), 3.45 (m, 1H), 4.84–4.96 (m, 2H), 5.36–5.51 (m,
2H), 5.77–5.88 ppm (m, 1H); 13CNMR (75 MHz, CDCl 3): d = 5.0, (u),
7.1 (d), 15.4 (d), 18.2 (d), 30.2 (u), 32.6 (u), 42.4 (d), 75.7 (d), 114.0 (u),
124.7 (d), 133.5 (d), 139.0 ppm (d); IR (neat): n˜ = 3075 (m), 2955 (w),
2880 (w), 1640 (m), 1454 (s), 1238 (s), 1080 (w), 1012 (w), 970 (s),
825 cmꢁ1 (s); MS (EI, 70 eV): m/z (%): 199 (100), 143 (6), 115 (38), 87
(22); HRMS (EI, 70 eV): m/z: calcd for C11H23OSi: 199.1518 [M+
ꢁC5H9]; found: 199.1519.
Triethyl (ꢁ)-(E,2S,3R)-3-isopropylhept-4,6-dien-2-yloxy)silane [(E)-9ad]:
[a]D = ꢁ75.8 (c= 1.04 in Et2O); GC: tR
=
7.23 min (S1); 1H NMR
(400 MHz, CDCl3): d = 0.57 (brq, J = 7.9 Hz, 6H), 0.80 (d, J = 6.7 Hz,
3H), 0.91 (d, J = 6.7 Hz, 3H), 0.95 (t, J = 7.9 Hz, 9H), 1.09 (d, J =
6.2 Hz, 3H), 1.57 (ddd, J = 10.0, 7.2, 4.0 Hz, 1H), 1.77 (o, J = 6.8 Hz,
1H), 3.99 (qd, J = 6.2, 4.0 Hz, 1H), 4.95 (dd, J = 10.0, 1.7 Hz, 1H), 5.07
(dd, J = 16.8, 1.7 Hz, 1H), 5.61 (dd, J = 15.2, 10.0 Hz, 1H), 5.98 (dd, J
= 15.2, 10.2 Hz, 1H), 6.35ppm (dt, J = 16.8, 10.1 Hz, 1H); 13CNMR
(100 MHz, CDCl3): d = 5.2 (u), 6.9 (d), 20.2 (d), 21.6 (d), 22.8 (d), 28.4
(d), 57.9 (d), 68.7 (d), 114.3 (u), 133.4 (d), 134.6 (d), 137.5 ppm (d); GC-
MS (EI, 70 eV): m/z (%): 268 [M+] (1), 267 (5), 253 (2), 241 (4), 240
(16), 239 [M+ꢁC2H5] (97), 219 (12), 204 (12), 203 (78), 195 (10), 159
(100), 157 (15), 155 (9), 137 (24), 131 (Et3SiO, 12), 115 (Et3Si, 3), 103 (5),
95 (8), 81 (14); IR (capillary): n˜ = 3086 (w), 3037 (w), 2957 (vs), 2911 (s),
2877 (vs), 2733 (w), 1796 (w), 1651 (w), 1603 (w), 1460 (m), 1415 (m),
1383 (m), 1372 (m), 1357 (m), 1323 (w), 1264 (w), 1239 (m), 1159 (s),
1129 (s), 1109 (s), 1070 (s), 1005 (vs), 958 (s), 939 (m), 895 (s), 852 (w),
A
:
tR = 9.58 min; [a]D = +5.2 (c= 0.6 in CH2Cl2); 1H NMR (300 MHz,
CDCl3): d = 0.52–0.57 (m, 6H), 0.85 (d, J = 6.9 Hz, 3H), 0.89 (m, 9H),
1.35–1.42 (m, 2H), 1.54 (d, J = 1.5 Hz, 3H), 1.62 (d, J = 1.2 Hz, 3H),
1.86–1.99 (m, 1H), 1.99–2.14 (m, 1H), 2.34–2.46 (m, 1H), 3.46 (dq, J =
9.9, 3.71, 1H), 4.84–4.94 (m, 2H), 4.96 (m, 1H), 5.68–5.82 ppm (m, 1H);
IR (neat): n˜ = 2927 (w), 2875 (s), 1637 (s), 1458 (m), 1216 (s), 1156 (m),
1011 (m), 912 (m), 759 cmꢁ1 (w); GC-MS (EI, 70 eV): m/z (%):253 [M+
ꢁ29] (6), 200 (17), 199 (100), 143 (12), 115 (95), 103 (28), 87 (44), 67
(28); HRMS (EI, 70 eV): m/z: calcd for C15H29OSi: 253.1987 [M+
ꢁC2H5]; found: 253.1989.
820 cmꢁ1 (w). (Z)-9ad: GC :tR
=
7.47 min (S1); 1H NMR (400 MHz,
CDCl3, in part): d = 0.81 (d, J = 6.9 Hz, 3H), 4.04 (qd, J = 6.1, 3.5 Hz,
1H), 5.05 (brd, J = 10.0 Hz, 1H), 5.17 (dd, J = 17.0, 1.7 Hz, 1H), 5.44
(t, J = 11.0 Hz, 1H), 6.19 (t, J = 11.0 Hz, 1H), 6.35 ppm (dt, J = 17.0,
10.5 Hz, 1H).
(5S,6R,7Z,9E,11R,12S)-5,12-Di(but-3-enyl)-3,3,14,14-tetraethyl-6,11-
diiso-propyl-8-methyl-4,13-dioxa-disilahexadeca-7,9-diene
GC: tR = 20.51 min; H NMR (400 MHz, CDCl3): d
[(Z,E)-17b]:
0.50–0.58 (m,
=
(7Z,9E,5S,6R,11S,12S)-3,3,14,14-Tetraethyl-6,11-diisopropyl-5,12-dimeth-
12H), 0.90 (t, J = 7.7 Hz, 18H), 0.96 (d, J = 6.9 Hz, 3H), 1.01 (d, J =
6.6 Hz, 3H), 1.35–1.44 (m, 4H), 1.66 (d, J = 1.1 Hz, 3H), 1.88–2.02 (m,
2H), 2.02–2.12 (m, 2H), 2.34–2.38 (m, 1H), 2.64–2.71 (m, 1H), 3.47–3.57
(m, 2H), 4.84–4.97 (m, 4H), 5.07 (d, J = 9.7 Hz, 1H), 5.50 (m, 1H),
5.68–5.79 (m, 2H), 6.32 ppm (d, J = 15.65 Hz, 1H); GC-MS (EI, 70 eV):
m/z (%): 520 [M+], 333 (1), 199 (100), 115 (36), 87 (25), 67 (11).
yl-8-vinyl-4,13-dioxa-3,14-disilahexadeca-7,9-diene
[(Z,E)-17ab]:
1H NMR (300 MHz, CDCl3): d = 0.57 (m, 12H), 0.82 (d, J = 6.9 Hz,
3H), 0.84 (d, J = 6.9 Hz, 3H), 0.94 (m, 24H), 1.06 (d, J = 6.1 Hz, 3H),
1.11 (d, J = 6.1 Hz, 3H), 1.57 (ddd, J = 9.7, 7.8, 3.1 Hz, 1H), 1.78 (m,
2H), 2.15 (ddd, J = 10.7, 8.0, 3.6 Hz, 1H), 4.04 (qd, J = 6.1, 3.1 Hz,
1H), 4.04 (qd, J = 6.1, 3.6 Hz, 1H), 4.98 (dd, J = 10.7, 1.7 Hz, 1H), 5.27
(dd, J = 17.2, 1.7 Hz, 1H), 5.52 (brd, J = 10.7 Hz, 1H), 5.62 (dd, J =
16.2, 9.9 Hz, 1H), 5.97 (brd, J = 16.2 Hz, 1H), 6.46 ppm (dd, J = 17.2,
10.7 Hz, 1H); 13CNMR (75 MHz, CDCl 3): d = 5.27 (u), 5.28 (u), 7.0 (d),
20.5 (d), 20.9 (d), 21.4 (d), 21.6 (d), 22.8 (d), 23.0 (d), 28.5, 29.0 (d), 51.9
(d), 58.9 (d), 68.8 (d), 68.9 (d), 112.9 (u), 128.0 (d), 131.5 (d), 133.0 (d),
139.7 (d), 144.3 ppm (u).
Reaction of( Z)-2c with LiCuMe2:
A suspension of CuI (249 mg,
1.3 mmol) in Et2O (10 mL) at ꢁ408Cwas treated with MeLi (1.05 mL,
2.4 mmol). After the yellow mixture was stirred for 1 h, the lithioalkenyl
sulfoximine (Z)-2c, which was prepared from (Z)-1c (200 mg,
0.43 mmol) and MeLi (0.22 mL of 5% solution in Et2O, 0.43 mmol), in
Et2O (2 mL) was transferred through a cannula to the mixture. The mix-
ture was stirred for 1 h at ꢁ408Cand allowed to warm room temperature
and stirred for 8 h. Then the mixture was quenched with D2O and ex-
tracted with Et2O. The combined organic phases were dried (MgSO4)
and concentrated in vacuo. A 1H NMR spectrum showed the formation
of [D]-(E)-9c and 16c in a ratio of 7:3). Purification by chromatography
(hexane/EtOAc 98:2) gave [D]-(E)-9c (71 mg, 50%) and 16c (28 mg,
19%) as colorless liquids.
Reaction of( Z)-2b with LiCuMe2
a) A suspension of CuI (140 mg, 0.73 mmol) in Et2O (5 mL) at ꢁ408C
was treated with MeLi (0.6 mL of 5% solution in Et2O, 1.34 mmol).
After the yellow mixture was stirred for 1 h, the lithioalkenyl sulfoximine
(Z)-2b, which was prepared from the alkenyl sulfoximine (Z)-1b
(100 mg, 0.25 mmol) and MeLi (0.12 mL of 5% solution in Et2O,
0.27 mmol), in Et2O (2 mL) was added. The mixture was stirred for 1 h at
ꢁ408Cand then allowed to warm room temperature and stirred for 8 h.
The mixture was quenched with aqueous NH4Cl and extracted with Et2O.
The combined organic phases were dried (MgSO4) and concentrated in
vacuo. Purification by column chromatography (hexane) gave a mixture
of alkene (E)-9b and dimethyl alkene 16b (39 mg) in a ratio of 7:3 as a
colorless liquid. GC-MS analysis showed the formation of (E)-9b and
16b together with 5% of diene (Z,E)-17b. Separation by HPLC(pen-
tane) gave (E)-9b (27 mg, 41%) and 16b (12 mg, 18%) as colorless liq-
uids.
tert-Butyl (1R,2R,E)-2-isopropyl-1-phenylpent-3-enyloxy)dimethylsilane
([D]-(E)-9c): [a]D = +60.4 (c= 0.7 in CH2Cl2); 1H NMR (400 MHz,
CDCl3): d = ꢁ0.27 (s, 3H), 0.0 (s, 3H), 0.78 (d, J = 6.9 Hz, 3H), 0.84 (s,
9H), 0.85 (d, J = 7.2 Hz, 3H), 1.43–1.52 (m, 1H), 1.64 (d, J = 1.1 Hz,
3H), 1.87 (dt, J = 11.5, 5.8 Hz, 1H), 4.63 (d, J = 6.0 Hz, 1H), 5.30 (d, J
= 9.9 Hz, 1H), 7.17–7.29 ppm (m, 5H, Ph); 13C NMR (75 MHz, CDCl3):
d = ꢁ4.8 (d), ꢁ4.2 (d), 18.1 (d), 18.3 (u), 18.8 (d), 22.0 (d), 25.9 (d), 27.8
(d), 58.7 (d), 76.4 (d), 126.6 (d), 126.9 (d), 127.4 (d), 129.0 (d), 144.7 ppm
(u); IR (KBr): n˜ = 3029 (w), 2956 (s), 2888 (s), 2859 (s), 1464 (s), 1364
(m), 1253 (s), 1200 (w), 1126 (m), 1089 (s), 1067 (s), 976 (m), 870 cmꢁ1
Chem. Eur. J. 2008, 14, 6510 – 6528
ꢁ 2008 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
6525